Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank93
3Y CAGR+0.3%
5Y CAGR+50.0%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+0.3%/yr
vs +103.2%/yr prior
5Y CAGR
+50.0%/yr
Recent deceleration
Acceleration
-102.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
7.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$3.55M-46.2%
2024$6.59M+99.1%
2023$3.31M-5.8%
2022$3.51M+183.0%
2021$1.24M+166.0%
2020$466785.00+118.9%
2019$213194.00+3.5%
2018$205994.00+12.5%
2017$183064.00-
2016$0.00-